June 7 (Reuters) - Kazia Therapeutics Ltd (KZA) :
- PHASE II STUDY OF PAXALISIB IN BRAIN METASTASES ADVANCES TO EXPANSION STAGE IN BREAST CANCER BRAIN METASTASES COHORT
News: KZA Kazia Says Phase II Study Of Paxalisib In Brain Metastases Advances To Expansion Stage In...
Add to My Watchlist
What is My Watchlist?